News and Articles - 2017
Chemical M&A and IPOs - A Warped View - Young & Partners (ICIS Chemical Business Nov. 10 - 16, 2017 issue)Amid talk of a hot M&A market and IPOs, if you take a hard look at the numbers, reality is different
Pharma and Biotech Markets (Young & Partners article in Pharma Executive eBook) Sept 2017Young & Partners examines the biopharma stock market and M&A trends and their implications
The Highs, Lows and the Unexpected - Young & Partners (ICIS Chemical Business Sept 8 - 14, 2017 issue) Young & Partners' observations about chemical industry's stock market performance and financings (debt and equity)
Fire and Ice - Chemical Mergers and Acquisitions- Young & Partners (ICIS Chemical Business Sept 1 -7, 2017 issue)While the M&A dollar volume is hot, a look behind the numbers shows that not everything is, or will be
Peter Young - Chemical Heritage Foundation Bolte Award (2017)Chemical Heritage to give the Richard J. Bolte Sr. Award to Peter Young of Young & Partners on Heritage Day
Calm Before The Storm - Young & Partners (ICIS Chemical Business May 19 - 25, 2017 issue)First Quarter M&A volume was modest, but we are heading for a monster year in M&A in terms of dollar volume
Pharma and Biotech Markets - Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017) Peter Young offers a summary of the strategic, stock market, M&A and financing issues facing the biopharma industry
In M&A, Now You See It, Now You Don't - Young & Partners ICIS Chemical Business Feb 24, 2017 issue)Young & Partners presents its contrarian analysis of what happened last year in global M&A and the outlook.
Chemical Financing Hits Record Levels - Young & Partners (ICIS Chemical Business Feb 17, 2017 Issue)Young & Partners analyzes the record dollar value of debt and equity financing in chemicals
Pharma and Biotech Markets - Challenges and Opportunities (Pharma Exec January 2017 Issue)Peter Young examines what is happening in the M&A and Equity Financing Markets and the Implications for Management